Our commitment to women’s healthcare and our delivery capabilities are epitomized in our line of anti-infective products for treating bacterial vaginosis and vaginal yeast infections. These products encompass an advanced bioadhesion technology called Site Release®, a drug delivery system that facilitates the release of medication with minimal systemic absorption and leakage.1